Table for the 8 triples with object "The FDA notes that this is a "moderate" CYP3A inhibitor in vivo in it most recent guidance document. See Table 5, p22" sorted by label

SubjectPredicate
?:evidence_1022?:content
?:evidence_1094?:content
?:evidence_1396?:content
?:evidence_1438?:content
?:evidence_1484?:content
?:evidence_1543?:content
?:evidence_1623?:content
?:evidence_1902?:content